Related references
Note: Only part of the references are listed.Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomes
Haishan Zhao et al.
MEDICAL ONCOLOGY (2015)
Inhibition of the JAK2/STAT3 Pathway Reduces Gastric Cancer Growth In Vitro and In Vivo
Louise M. Judd et al.
PLOS ONE (2014)
OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
Mi-Jung Kim et al.
CANCER LETTERS (2013)
Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma
Jiaxin Xie et al.
HEPATOLOGY (2013)
Down-regulation of GRIM-19 is associated with STAT3 overexpression in breast carcinomas
Tao Zhou et al.
HUMAN PATHOLOGY (2013)
JAK/STAT/SOCS-signaling pathway and colon and rectal cancer
Martha L. Slattery et al.
MOLECULAR CARCINOGENESIS (2013)
Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma
Yingtai Chen et al.
LEUKEMIA RESEARCH (2013)
Activation of IL-6R/JAK1/STAT3 Signaling Induces De Novo Resistance to Irreversible EGFR Inhibitors in Non-Small Cell Lung Cancer with T790M Resistance Mutation
Sun Mi Kim et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Differential roles of STAT3 depending on the mechanism of STAT3 activation in gastric cancer cells
W. Okamoto et al.
BRITISH JOURNAL OF CANCER (2011)
Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph)
Katja Butterbach et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Cancer: More of Polygenic Disease and Less of Multiple Mutations? A Quantitative Viewpoint
Anders Bredberg
CANCER (2011)
Genetic Polymorphisms in Inflammation Pathway Genes and Prostate Cancer Risk
Erika M. Kwon et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Association of Signal Transducer and Activator of Transcription 3 Gene Polymorphisms with Cervical Cancer in Chinese Women
Kana Wang et al.
DNA AND CELL BIOLOGY (2011)
STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer
B. Jiang et al.
GENETICS AND MOLECULAR RESEARCH (2011)
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon alpha
Sebastian Kreil et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Molecular epidemiology of cancer
D. G. Zaridze
BIOCHEMISTRY-MOSCOW (2008)
STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma
Noriyuki Ito et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer
Annika Vaclavicek et al.
ENDOCRINE-RELATED CANCER (2007)
Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines - Inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells
Q Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Association studies for finding cancer-susceptibility genetic variants
PDP Pharoah et al.
NATURE REVIEWS CANCER (2004)
STATs: Transcriptional control and biological impact
DE Levy et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Share Paper
